跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BCL-16
首页
药物
BCL-16
BCL-16
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Monocyclic diazodioxide based Bcl-2 protein antagonists related applications
申请人: GUPTA SANDEEP
优先权: 2004
US
Traditional Chinese medicine composition for treating leukemia by adjusting BCL family and preparation method thereof
申请人: XIAMEN MIAI 9 SCIENCE AND TECH DEVELOPMENT LIMITED COMPANY
优先权: 2020
CN
BCL-XL VARIANTS FOR ENHANCING CELLULAR IMMUNOTHERAPY FUNCTION
申请人: H LEE MOFFITT CANCER CT & RES
优先权: 2024
WO
Synthesis method for BCL-2 inhibitor Venetoclax
申请人: HANGZHOU KEYAO MEDICINE TECH CO LTD
优先权: 2017
CN
Traditional Chinese medicine compound for treating bortezomib-induced peripheral neuropathy and application thereof
申请人: THE SECOND AFFILIATED HOSPITAL OF SHANDONG UNIV OF TRADITIONAL CHINESE MEDICINE SHANDONG INTEGRATED
优先权: 2024
CN
药物
反馈